A Systematic Review of the Association of Obesity with the Outcomes of Inflammatory Rheumatic Diseases

Overview

Journal Singapore Med J

Specialty General Medicine

Date 2019 Jun 28

PMID 31243460

Citations 7

Authors

Yi Xuan Lee

Yu Heng Kwan

Ka Keat Lim

Chuen Seng Tan

Nai Lee Lui

Jie Kie Phang

Eng Hui Chew

Truls Ostbye

Julian Thumboo

Warren Fong

Affiliations

Soon will be listed here.

Abstract

This was a systematic review of the literature on the association between obesity and the outcome of inflammatory rheumatic diseases. We conducted a literature search using PubMed®, Embase and PsycINFO®. Articles were classified into three categories based on the effects of obesity on the outcomes of inflammatory rheumatic diseases. The subject population, country, type of studies, number of patients, measurement of obesity and outcomes assessed were presented. Quality was appraised using Kmet et al's criteria. 4,331 articles were screened and 60 were relevant to the objective. Obesity had a negative, positive and neutral association with outcomes of inflammatory rheumatic diseases in 38 (63.3%) studies with 57,612 subjects, 11 (18.3%) studies with 3,866 subjects, and 11 (18.3%) studies with 3,834 subjects, respectively. In most studies, the disease population had been diagnosed with rheumatoid arthritis (RA). Tumour necrosis factor-α inhibitors were mostly associated with negative outcomes. More studies examining subjects outside Europe and North America and diseases other than RA are warranted.

Citing Articles

Body Mass Index Profile of Adult Patients with Inflammatory Bowel Disease in a Multicenter Study in Northeastern Brazil.

Lima J, de Brito C, Celani L, de Araujo M, de Lucena M, Vasconcelos G Clin Exp Gastroenterol. 2023; 16:213-224.

PMID: 38023814 PMC: 10656846. DOI: 10.2147/CEG.S436699.

Changes in body weight and body composition in patients with active rheumatoid arthritis aged 65+ treated with 2-year low-dose add-on prednisolone in the randomised double-blind placebo-controlled GLORIA trial.

Guler-Yuksel M, Kuijper M, Bos R, Molenaar E, Emmering J, Eshuis S RMD Open. 2023; 9(2).

PMID: 37349120 PMC: 10314614. DOI: 10.1136/rmdopen-2022-002905.

Cardiovascular health worsening in patients with autoimmune rheumatological diseases during the COVID-19 pandemic.

Galarza-Delgado D, Azpiri-Lopez J, Colunga-Pedraza I, Cardenas-de la Garza J, Gonzalez-Gonzalez V, Beltran-Aguilar V Clin Rheumatol. 2023; 42(10):2677-2690.

PMID: 36627529 PMC: 9838353. DOI: 10.1007/s10067-022-06486-4.

Minimal disease activity and remission in patients with psoriatic arthritis with elevated body mass index: an observational cohort study in the Swiss Clinical Quality Management cohort.

Vallejo-Yague E, Burkard T, Micheroli R, Burden A BMJ Open. 2022; 12(9):e061474.

PMID: 36115672 PMC: 9486340. DOI: 10.1136/bmjopen-2022-061474.

Baseline predictors of remission, pain and fatigue in rheumatoid arthritis: the TITRATE trial.

Lee S, Ibrahim F, Tom B, Nikiphorou E, Williams F, Lempp H Arthritis Res Ther. 2021; 23(1):278.

PMID: 34736525 PMC: 8567573. DOI: 10.1186/s13075-021-02653-1.

References

Kaufmann J, Kielstein V, Kilian S, Stein G, Hein G . Relation between body mass index and radiological progression in patients with rheumatoid arthritis. J Rheumatol. 2003; 30(11):2350-5. View

Uutela T, Kautiainen H, Jarvenpaa S, Salomaa S, Hakala M, Hakkinen A . Waist circumference based abdominal obesity may be helpful as a marker for unmet needs in patients with RA. Scand J Rheumatol. 2014; 43(4):279-85. DOI: 10.3109/03009742.2013.858769. View

Jawaheer D, Olsen J, Lahiff M, Forsberg S, Lahteenmaki J, da Silveira I . Gender, body mass index and rheumatoid arthritis disease activity: results from the QUEST-RA Study. Clin Exp Rheumatol. 2010; 28(4):454-61. PMC: 3012645. View

Ibn Yacoub Y, Amine B, Laatiris A, Wafki F, Znat F, Hajjaj-Hassouni N . Prevalence of overweight in Moroccan patients with rheumatoid arthritis and its relationships with disease features. Clin Rheumatol. 2011; 31(3):479-82. DOI: 10.1007/s10067-011-1874-3. View

Katz P, Yazdany J, Julian L, Trupin L, Margaretten M, Yelin E . Impact of obesity on functioning among women with systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2011; 63(10):1357-64. PMC: 3183275. DOI: 10.1002/acr.20526. View

Baker J, Ostergaard M, George M, Shults J, Emery P, Baker D . Greater body mass independently predicts less radiographic progression on X-ray and MRI over 1-2 years. Ann Rheum Dis. 2014; 73(11):1923-8. PMC: 4809044. DOI: 10.1136/annrheumdis-2014-205544. View

Gremese E, Carletto A, Padovan M, Atzeni F, Raffeiner B, Giardina A . Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine. Arthritis Care Res (Hoboken). 2012; 65(1):94-100. DOI: 10.1002/acr.21768. View

Westhoff G, Rau R, Zink A . Radiographic joint damage in early rheumatoid arthritis is highly dependent on body mass index. Arthritis Rheum. 2007; 56(11):3575-82. DOI: 10.1002/art.23033. View

Micheroli R, Hebeisen M, Wildi L, Exer P, Tamborrini G, Bernhard J . Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis. Arthritis Res Ther. 2017; 19(1):164. PMC: 5518107. DOI: 10.1186/s13075-017-1372-3. View

10.

Giles J, Bartlett S, Andersen R, Thompson R, Fontaine K, Bathon J . Association of body fat with C-reactive protein in rheumatoid arthritis. Arthritis Rheum. 2008; 58(9):2632-41. PMC: 2671067. DOI: 10.1002/art.23766. View

11.

Gremese E, Bernardi S, Bonazza S, Nowik M, Peluso G, Massara A . Body weight, gender and response to TNF-α blockers in axial spondyloarthritis. Rheumatology (Oxford). 2014; 53(5):875-81. DOI: 10.1093/rheumatology/ket433. View

12.

Velpula U, Agrawal S, Thomas J, Prabu V, Rajasekhar L, Narsimulu G . Low body mass index is adversely associated with radiographic joint damage in Indian patients with early rheumatoid arthritis. J Rheumatol. 2010; 38(3):434-8. DOI: 10.3899/jrheum.100535. View

13.

Iannone F, Fanizzi R, Scioscia C, Anelli M, Lapadula G . Body mass does not affect the remission of psoriatic arthritis patients on anti-TNF-α therapy. Scand J Rheumatol. 2012; 42(1):41-4. DOI: 10.3109/03009742.2012.715186. View

14.

. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004; 363(9403):157-63. DOI: 10.1016/S0140-6736(03)15268-3. View

15.

Daien C, Sellam J . Obesity and inflammatory arthritis: impact on occurrence, disease characteristics and therapeutic response. RMD Open. 2015; 1(1):e000012. PMC: 4613154. DOI: 10.1136/rmdopen-2014-000012. View

16.

Klaasen R, Wijbrandts C, Gerlag D, Tak P . Body mass index and clinical response to infliximab in rheumatoid arthritis. Arthritis Rheum. 2011; 63(2):359-64. DOI: 10.1002/art.30136. View

17.

Escalante A, Haas R, del Rincon I . Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Arch Intern Med. 2005; 165(14):1624-9. DOI: 10.1001/archinte.165.14.1624. View

18.

George M, Ostergaard M, Conaghan P, Emery P, Baker D, Baker J . Obesity and rates of clinical remission and low MRI inflammation in rheumatoid arthritis. Ann Rheum Dis. 2017; 76(10):1743-1746. DOI: 10.1136/annrheumdis-2017-211569. View

19.

Ottaviani S, Gardette A, Tubach F, Roy C, Palazzo E, Gill G . Body mass index and response to infliximab in rheumatoid arthritis. Clin Exp Rheumatol. 2015; 33(4):478-83. View

20.

DAgostino M, Alten R, Mysler E, Le Bars M, Ye J, Murthy B . Body mass index and clinical response to intravenous or subcutaneous abatacept in patients with rheumatoid arthritis. Clin Rheumatol. 2017; 36(12):2655-2665. PMC: 5681604. DOI: 10.1007/s10067-017-3788-1. View